Finding accredited CPD
Prostate Cancer Research Review Issue 85 with commentary by Professor Niall Corcoran.
This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in Prostate Cancer. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.
In this issue we feature:
- Myeloid-mediated immunotherapy resistance in prostate cancer
- Personalised dynamic prediction model in active surveillance
- Sequencing cabazitaxel and 177Lu-PSMA-617
- 10-year outcomes of stereotactic radiation therapy
- Natural history of PIRADS-2 lesions
- Immune response after irreversible electroporation
- Risk stratification of high-risk and locoregional prostate cancer
- Gene expression classifier and adjuvant treatment after radical prostatectomy
- Biparametric vs multiparametric MRI
- Pelvic lymph node dissection in prostate cancer
To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au
This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide.
Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.
You have to log in to see the content of this module.
Provided by
Accepted by